Search Results
Event
On March 12-16, 2024, the National Human Genome Research Institute (NHGRI) will participate in the 2024 ACMG Annual Clinical Genetics Meeting - an annual medical and scientific conference continues to provide groundbreaking research and the latest advances in medical genetics, genomics and personalized medicine.
… in the All of Us Research Program Clinical Genetics and Therapeutics Session A March 14, 2024, 4:15 – 5:45 p.m … in Patients with Alkaptonuria Biochemical/Metabolic and Therapeutics March 14, 2024, 4:15 – 5:45 p.m MTCC-701 … Creatine Deficiency Syndromes Biochemical/Metabolic and Therapeutics … Poster Presentations  No. Title P006 …
Staff
Dr. Michael Erdos is an Associate Investigator in the Molecular Genetics Section of the Center for Precision Health Research.
… translational research to identify and validate potential therapeutics for the rare premature-aging disease, Hutchinson … useful model for preclinical investigation of potential therapeutics, particularly for genetic therapies, because the … human LMNA DNA sequence. In the realm of small molecule therapeutics, farnesyl transferase inhibitors (FTIs) target …
Fact Sheets
Cloning describes a number of different processes that can be used to produce genetically identical copies of a biological entity.
News Release
NHGRI has appointed Neil Hanchard, M.D., Ph.D., as a clinical investigator within the Medical Genomics and Metabolic Genetics Branch (MGMGB) in the Division of Intramural Research. Dr. Hanchard will head the Childhood Complex Disease Genomics Section within the MGMGB.
Graduate Medical Education
An opportunity for a 4-to-8-week elective in the National Human Genome Research Institute (NHGRI) at the NIH Clinical Center in Bethesda, MD.
… Informatics Cardiology Clinical Pharmacology and Therapeutics for Senior Medical Students Critical Care …
Staff
Dr. Laura Elnitski is a senior investigator in the Translational and Functional Genomics Branch at the National Human Genome Research Institute.
​
Staff
William J. Pavan, Ph.D. is the chief of NHGRI's Genetic Disease Research Branch.
… therapeutic compounds via high-throughput screens, its Therapeutics for Rare and Neglected Diseases program to …
Event
The Advances in Genomic Technology Development (AGTD) 2023 Annual Meeting was hosted by the Technology Development Coordinating Center (TDCC) in-person and virtually from Tuesday, June 6, until Thursday, June 8, at The Sanford Consortium for Regenerative Medicine, La Jolla, CA.
… San Diego 10:30 a.m. Fernando Aleman, Ph.D., Navega Therapeutics Aaron Parker, Ph.D., J.D., Bristol Myers Squibb … Gonzales, Ph.D., Goodwin Katannya Kapeli, Ph.D., Trotana Therapeutics aclyn Einstein, Ph.D., Trotana Therapeutics Sergio Duron Ph.D., Enlaza Therapeutics Adam …
Media Advisory
On May 30, 2024 at 10:00 AM ET, RNA experts will discuss the recently released NASEM report and what it means for the future of RNA research and genomics.
… be simpler and less invasive than other options. RNA-based therapeutics are also being developed and trialed as targeted … sequencing, RNA modifications, RNA synthesis and RNA-based therapeutics. Policy, workforce and infrastructure needs to …
Research at NHGRI
The Translational and Functional Genomics Branch explores the genetic, epigenetic and metagenomic basis of human disorders.
… translate laboratory findings into improved diagnoses and therapeutics for human disorders. … Overview … Branch Staff … …